China Medical System Holdings Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
6,415
- Stock Symbol
-
00867
- Investments
-
31
- Share Price
-
$1.18
- (As of Friday Closing)
China Medical System Holdings General Information
Description
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
Contact Information
Website
www.cms.net.cnCorporate Office
- Room 2106, 21/F, Harbour Tower
- 510 King's Road North Point
- Hong Kong, 518057
- Hong Kong
Corporate Office
- Room 2106, 21/F, Harbour Tower
- 510 King's Road North Point
- Hong Kong, 518057
- Hong Kong
China Medical System Holdings Stock Performance
As of 20-Nov-2026, China Medical System Holdings’s stock price is $1.18. Its current market cap is $2.86B with 2.43B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.18 | $1.22 | $1.16 - $1.98 | $2.86B | 2.43B | 4.76M | $0.09 |
China Medical System Holdings Financials Summary
As of 30-Jun-2026, China Medical System Holdings has a trailing 12-month revenue of $1.24B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,488,020 | 3,333,805 | 1,679,410 | 3,692,469 |
| Revenue | 1,244,871 | 1,141,940 | 1,040,907 | 1,132,639 |
| EBITDA | 304,813 | 320,934 | 304,066 | 424,475 |
| Net Income | 219,199 | 207,040 | 225,740 | 339,361 |
| Total Assets | 2,895,459 | 2,743,987 | 2,472,266 | 2,501,317 |
| Total Debt | 129,952 | 98,629 | 117,908 | 183,638 |
China Medical System Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
China Medical System Holdings Signals
China Medical System Holdings Investments & Acquisitions (31)
China Medical System Holdings’s most recent deal was a Early Stage VC with Beyond Therapeutics for . The deal was made on 14-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Beyond Therapeutics | 14-Jul-2026 | Early Stage VC | Drug Discovery | ||
| Tyligand Bioscience | 26-Jan-2026 | Later Stage VC | Drug Discovery | ||
| Eastenova | 26-Mar-2025 | Later Stage VC | Biotechnology | ||
| Baiyiyuan Biotech | 23-Jan-2025 | Later Stage VC | Medical Supplies | ||
| Eastenova | 07-Oct-2023 | Later Stage VC | Biotechnology |
China Medical System Holdings ESG
Risk Overview
Risk Rating
Updated November, 17, 2026
25.34 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
China Medical System Holdings Exits (7)
China Medical System Holdings’s most recent exit was on 28-Nov-2022 from Zhuhai Trinomab Pharmaceutical. The exit was categorized as with 8 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Zhuhai Trinomab Pharmaceutical | 28-Nov-2022 | Completed |
|
||
| Zhuhai Trinomab Pharmaceutical | 27-Nov-2022 | Completed |
|
||
| Heling Pharmaceutical | 23-Mar-2022 | Completed |
|
||
| Gelesis | 14-Jan-2022 | Completed |
|
||
| Zhuhai Trinomab Pharmaceutical | 25-Apr-2021 | Later Stage VC | Completed |
|
China Medical System Holdings Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CMS Ventures | Cambridge, United Kingdom | 2020 | |
| Tibet Kangzhe Pharmaceutical | Lhasa, China | 2006 |
China Medical System Holdings FAQs
-
When was China Medical System Holdings founded?
China Medical System Holdings was founded in 2006.
-
Where is China Medical System Holdings headquartered?
China Medical System Holdings is headquartered in Hong Kong, Hong Kong.
-
What is the size of China Medical System Holdings?
China Medical System Holdings has 6,415 total employees.
-
What industry is China Medical System Holdings in?
China Medical System Holdings’s primary industry is Holding Companies.
-
Is China Medical System Holdings a private or public company?
China Medical System Holdings is a Public company.
-
What is China Medical System Holdings’s stock symbol?
The ticker symbol for China Medical System Holdings is 00867.
-
What is the current stock price of China Medical System Holdings?
As of 20-Nov-2026 the stock price of China Medical System Holdings is $1.18.
-
What is the current market cap of China Medical System Holdings?
The current market capitalization of China Medical System Holdings is $2.86B.
-
What is China Medical System Holdings’s current revenue?
The trailing twelve month revenue for China Medical System Holdings is $1.24B.
-
What is China Medical System Holdings’s annual earnings per share (EPS)?
China Medical System Holdings’s EPS for 12 months was $0.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process